AnalystsMichael FreemanMichael Freeman's Stock Forecasts
AnalystsMichael Freeman
Sectors:
Analyst Ranking
Bottom 30%
#3733 out of 5290 analysts
Average Return
-0.91%
Win Rate
50%3 out of 6
Risk vs Reward
Poor
Good
Michael Freeman's 5 best and worst ratings
Michael Freeman Analyst Color
Get additional color on Michael Freeman's coverage of popular stocks
Michael Freeman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tectonic Therapeutic IncTECX | 2 | Strong Buy | $81.00 | +179.31% | Upgrades | 11 days ago |
Wave Life Sciences LtdWVE | 1 | Buy | $14.00 | +144.33% | Assumes | a year ago |
Dyne Therapeutics IncDYN | 1 | Buy | $37.00 | +117.14% | Assumes | a year ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | +32.84% | Reinstates | a year ago |
Avidity Biosciences IncRNAM | 1 | Strong Buy | $65.00 | +340.68% | Initiates Coverage On | a year ago |
Bausch Health Companies IncBHC | 1 | Hold | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.